Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock - Nakit Akışı (NASDAQ:FBIOP)

Financials

Genel Bakış Tablolar İstatistikler Temettüler

İşletme faaliyetlerinden elde edilen nakit -83.68 M-116.54 M-179.4 M-128.22 M-80.19 M-65.78 M 157.64 M Yatırım faaliyetlerinden elde edilen nakit -7.16 M40.51 M-22.93 M-2.1 M-15 M10.12 M 8.96 M Finansman faaliyetlerinden elde edilen nakit 172.41 M148.99 M75.32 M32.74 M70.64 M77.44 M -2.09 M Serbest nakit akışı -83.68 M-116.54 M-179.4 M-128.22 M-80.19 M-65.78 M 157.64 M

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

FBIOP

Financials

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Haberler

Fortress Biotech, Menkes hastalığı tedavisi için NDA başvurusunu yeniden sundu

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript

Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call Transcript